- Home
- UGI vs KRYS Comparison
UGI vs KRYS Comparison
Compare UGI & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UGI | KRYS |
|---|---|---|
| Founded | 1940 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.6B |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | UGI | KRYS |
|---|---|---|
| Price | $37.97 | $368.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $44.00 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 2.3M | 184.9K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | ★ 147.20 | 128.00 |
| EPS | 3.08 | ★ 3.62 |
| Revenue | ★ $7,287,000,000.00 | $389,130,000.00 |
| Revenue This Year | $8.88 | $38.74 |
| Revenue Next Year | $2.27 | $32.53 |
| P/E Ratio | ★ $12.38 | $102.13 |
| Revenue Growth | 1.07 | ★ 33.94 |
| 52 Week Low | $31.62 | $145.46 |
| 52 Week High | $41.34 | $382.54 |
Technical Indicators
Market Signals| Indicator | UGI | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 63.35 |
| Support Level | $35.84 | $253.89 |
| Resistance Level | $39.41 | $382.33 |
| Average True Range (ATR) | 1.05 | 10.15 |
| MACD | 0.05 | 3.38 |
| Stochastic Oscillator | 64.18 | 94.68 |
Price Performance
Historical ComparisonAbout UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.